The Advisory Team at IGM Biosciences provides strategic guidance and expertise to support the development and clinical advancement of the company's engineered IgM antibodies. Comprised of experienced advisors, the team offers insights on clinical trial design, regulatory pathways, and potential therapeutic applications to help optimize the efficacy and safety of IGM's cutting-edge biotechnology products.
View all